Mr. Dunn of Florida introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend the Public Health Services Act, commonly referred to as the Clinical Laboratory Improvement Amendments or CLIA, with respect to laboratory developed tests, and for other purposes.
21 U.S.C. 301, 321, 355, 360, 360e, 360j, 370c
and
379j 42 U.S.C. 1395y, 262
and
263a
Document Citations
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Enhancing Clinical Laboratory Innovation and Access Act of 2026. H.R. 8890. 119th
Cong., 2nd
sess., Introduced in House May 19, 2026. https://www.govinfo.gov/app/details/BILLS-119hr8890ih.
APA
Congress, House of Representatives (2026, May 19). Enhancing Clinical Laboratory Innovation and Access Act of 2026 (H.R. 8890 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr8890ih.
MLA
United States, Congress, House of Representatives. Enhancing Clinical Laboratory Innovation and Access Act of 2026. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr8890ih. 119th Congress, H.R. 8890, Introduced in House 19 May. 2026.
Bluebook
H.R.8890 - 119th Congress (2025-2026): Enhancing Clinical Laboratory Innovation and Access Act of 2026, H.R.8890, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr8890ih.
